VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $3,460,000 | +87.9% | 200,000 | +166.7% | 0.01% | +60.0% |
| Q3 2016 | $1,841,000 | -78.7% | 75,000 | -11.8% | 0.01% | -78.3% |
| Q4 2015 | $8,640,000 | -73.1% | 85,000 | -52.8% | 0.02% | -74.2% |
| Q3 2015 | $32,108,000 | +189.1% | 180,000 | +260.0% | 0.09% | +217.9% |
| Q2 2015 | $11,108,000 | +11.9% | 50,000 | 0.0% | 0.03% | +16.7% |
| Q1 2015 | $9,931,000 | -24.7% | 50,000 | -50.0% | 0.02% | -33.3% |
| Q1 2014 | $13,183,000 | +26.4% | 100,000 | 0.0% | 0.04% | +20.0% |
| Q3 2013 | $10,433,000 | +21.2% | 100,000 | 0.0% | 0.03% | +11.1% |
| Q2 2013 | $8,608,000 | -42.6% | 100,000 | -50.0% | 0.03% | -46.0% |
| Q1 2013 | $15,004,000 | – | 200,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |